Final results of a randomized trial comparing chemotherapy plus radiotherapy with chemotherapy plus surgery plus radiotherapy in locally advanced resectable hypopharyngeal carcinomas

Laryngoscope

Volumn 107, Issue 5, 1997, Pages 648-653

  Beauvillain, C ^a,e   Mahe M ^b   Bourdin, S ^b   Peuvrel, P ^b   Bergerot, P ^c   Riviere A ^d   Vignoud, J ^b   Deraucourt, D ^d   Wesoluch, M ^c  

^a NANTES UNIVERSITY HOSPITAL   (France)

^b CENTRE RENÉ GAUDUCHEAU   (France)

^c Department of Radiotherapy ^*  (France)

^d CENTRE FRANÇOIS BACLESSE   (France)

^e HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOPHARYNX CARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; SURGICAL APPROACH; TREATMENT OUTCOME;

EID: 0030993181     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-199705000-00017     Document Type: Article

References (14)

1. Silverberg E, Boring CC, Squires TS. Cancer statistics. Cancer 1990;40:9-26.
2. Million RR, Cassisi NJ. Hypopharynx: pharyngeal walls, pyriform sinus, and postcricoid pharynx. In: Million RR, Cassisi JJ, eds. Management of Head and Neck Cancer: A Multidisciplinary Approach. Philadelphia: Lippincott, 1984: 373-91
3. Shah JP, Shaha AR, Spiro RH, et al. Carcinoma of the hypopharynx. Am J Surg 1976;132:439-43.
4. Dimery IW, Hong WK. Overview of combined modality therapies for head and neck cancer. J Natl Cancer Inst 1993; 85:95-111.
5. Kotwall C, Sako K, Razack MS, et al. Metastatic patterns in squamous cell cancer of the head and neck. Am J Surg 1987;154:439-42.
6. Department of Veterans Affairs Laryngeal Cancer Study Group: Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 1991;324:1685-90.
7. Paccagnella A, Orlando A, Marchiori C, et al. Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: a study by the gruppo di studio sui tumori della testa e del collo. J Natl Cancer Inst 1994;86:265-72.
8. Jacobs C, Makuch R. Efficacy of adjuvant chemotherapy for patients with resectable head and neck cancer: a subset analysis of the Head and Neck Contracts Program. J Clin Oncol 1990;8:838-47.
9. Schuller DE, Metch B, Stein DW, et al. Preoperative chemotherapy in advanced resectable head and neck cancer: final report of the Southwest Oncology Group. Laryngoscope 1988;98:1205-11.
10. Laramore GE, Scott CB, al-Sarraf M, et al. Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: report on Intergroup study 0034. Int J Radiat Oncol Biol Phys 1992;23:705-13.
11. Lefebvre JL, Sahmoud T, for the EORTC Head and Neck Cancer Cooperative Group: Larynx preservation in hypopharynx squamous cell carcinoma: preliminary results of a randomized study (EORTC 24891)(Abstract 912). Proc Am Soc Clin Oncol 1994;13:283.
12. De Pooter CMJ, Scalliet PG, Elst HJ, et al. Resistance patterns between cts-diamminedichloroplatinum(II) and ionizing radiation. Cancer Res 1991;51:4523-27.
13. Ensley JF, Jacobs JR, Weaver A, et al. Correlation between response to cisplatinum-combination chemotherapy and subsequent radiotherapy in previously untreated patients with advanced squamous cell cancers of the head and neck. Cancer 1984;54:811-4.
14. Yokes EE, Mick R, Kies M, et al. Fluorouracil pharmacodynamics of induction chemotherapy in advanced head and neck cancer [abstract 854]. Proc Am Soc Clin Oncol 1995;14:297.